Introduction
The number of cytokines implicated in the pathogenesis of ischaemic cerebral stroke has grown considerably in recent years but as yet there is no great understanding of their associated intracellular signalling pathways. Cytokines activate many pathological processes, including cell adhesion, extravasation, angiogenesis, vasoconstriction and neurotoxicity [7, 27, 51] . However, the link molecules between cytokines produced during the initial phase of stroke, signal transduction activation and subsequent extension of the ischaemic penumbra are as yet undefined.
We reported previously that important cytokines for stroke pathology, angiogenesis and neuroprotection such as fibroblast growth factor 2 (FGF-2, unpub. data), transforming growth factor beta 1, vascular endothelial growth factor (VEGF), platelet-derived growth factor and brainderived neurotrophic factor (BDNF) are expressed shortly after the onset of stroke [9, 16, 18, 19, 46] . Growth factors and cytokines employ cell-specific, membrane-bound receptors to regulate signal transduction activity usually through activation of G-protein or tyrosine kinaseassociated effectors [24, 48] . Phosphorylation of intermediates such as protein kinase C, Src, PI-3 kinase and Ras form a cascade which results in stimulation primarily of members of the mitogen activated protein (MAP) kinase family which translocate to the nucleus and modulate cell survival or growth [33, 45] . The serine/threonine kinase Raf-1 and its downstream MEK-ERK cascade is well established [32] . Following activation, ERKs translocate to the nucleus and then phosphorylate and activate several transcription factors (c-fos, c-Jun, elk-1 and egr-1 genes) [3] . Studies of long-term survival suggest recovery of neuronal function in ischaemic penumbra could benefit from a constitutively activated MAP kinase pathway perhaps in association with VEGF expression [42, 47] . Another group of related kinases are the stress-activated protein kinases (SAPKs), p38 and c-Jun N-terminal kinase (JNK) [12, 20] . Generally, stimulation of these pathways (consistent with growth factor withdrawal) results in cell death. Activation of MEK3/6 results in phosphorylation of threonine and tyrosine residues of p38 culminating in modulation of ATF-2 and CHOP-1, whereas phosphorylation of JNK results in activation of both ATF-2 and c-Jun [12] . Inhibition of p38 MAP kinase phosphorylation by oral administration of the inhibitor SE 239063 1 h and 6 h after middle cerebral artery occlusion (MCAO) in the rat model significantly reduced neurological deficit and infarct size [5, 23] . Similarly, activation of c-Jun kinase by JNK, which becomes phosphorylated after MCAO may participate in cell death pathways [13, 39] . Other major subsets of cytokines utilize receptors with no direct tyrosine kinase activity, for example, Stat-1. Stats are tyrosine phosphorylated transcription factors activated by the JAK family kinases [14] . The phosphorylated protein forms dimers, which translocate to the nucleus, bind to response elements in target genes and activate transcription of proteins with, for example, growth inhibitory properties [22, 30] . Stat-1 is activated downstream of p38 MAP kinase under hypoxic conditions [6] . It is likely that optimum conditions for neuronal protection result from activation of several signal transduction pathways, initiated by a mixture of cytokines.
There are several reports on the role of signal transduction pathways after brain ischaemia but expression, distribution and time-course of phosphorylated forms were not studied after focal cortical brain ischaemia. Greater understanding of the intracellular mechanisms that occur after ischaemia may bring about closer effective strategies for the treatment of brain stroke.
Materials and methods

Animals and anaesthesia
Stroke experiments were performed on female SpragueDawley rats weighing 230-270 g which suffer less during ischaemia/traumatic insult perhaps because of higher endogenous steroid levels reducing free radical damage [2] . They were deliberately chosen as our intention was to produce small cerebral infarction. The animals were housed at 21 ∞ C with ad libitum access to food and water. Animal welfare was conducted according to regulations of the Real Decreto 223:1988, which makes recommendations similar to those of the NIH report Public Health Service Policy of the Care and Handling of Laboratory Animals.
Middle cerebral artery occlusion
Cerebral ischaemia was produced using a modified method of Tamura et al . [49] by distal, permanent occlusion of the middle cerebral artery (MCA) by electrocautery. The mortality in this model is very low. Anaesthesia was induced by 4% isoflurane in an O 2 /N 2 O mixture of the same concentration found in air, and maintained at 1-2% isoflurane in O 2 /N 2 O during the procedure. Body temperature was maintained after the surgical procedure by placing animals under heat lamps. Sets of six animals (three rats for morphological studies and three for protein studies) for each time-point were sacrificed at 10 min, 1, 4, 12, 24 and 48 h and 4 days, as well as 1 and 2 months (for immunohistochemistry study only). Sham-operated animals were used as controls and the MCA was exposed but not electrocoagulated.
Immunohistochemistry
For morphological studies and immunohistochemistry, rats were perfused through the heart with phosphate buff-ered saline (PBS) followed by 4% paraformaldehyde in PBS. Immediately afterwards, the brains were removed and fixed with the same fixative solution for 24 h at 4 ∞ C. Fixed brains were cryoprotected and stored at -70 ∞ C. For immunohistochemistry, 5 m m serial sections were cut with a cryostat. The avidin-biotin-peroxidase method was used for immunohistochemistry (ABC kit, Vectastain, Vector, UK). After blocking endogenous peroxidase, the sections were incubated with normal serum and then incubated at 4 ∞ C overnight with one of the following primary antibodies (Autogen Bioclear, Wiltshire, UK): anti-p-Stat-1 (goat polyclonal recognizing phosphorylated Tyr-701 of Stat-1), anti-p-ERK1/2 (mouse monoclonal recognizing phosphorylated Tyr-204 of ERK1/2), anti-p-JNK1/2 (mouse monoclonal recognizing phosphorylated Thr-183 and Tyr-185 of JNK1), anti-p-TY (PY99, mouse monoclonal), anti-p-MEK3/6 (mouse monoclonal recognizing phosphorylated Ser-189 and Ser-207 of MEK-3), anti-p-p38 (mouse monoclonal recognizing phosphorylated Tyr-182 of p38), antip-c-Jun (mouse monoclonal recognizing phosphorylated amino acids 56-68 of c-Jun), anti-p-elk-1 (mouse monoclonal recognizing phosphorylated ser-383 of elk-1). Sections were then incubated for 1 h with biotinylated antigoat IgG or antimouse antibodies diluted 1 : 100, and finally with ABC at a dilution of 1 : 100 for 1 h at room temperature. The peroxidase reaction was visualized with 0.05% w/v diaminobenzidine and 0.001% hydrogen peroxide. Specificity of the immunoreaction was tested by preincubation of the antibodies with the corresponding antigenic peptides prior to immunohistochemistry. Immunostaining was abolished in these sections.
Extraction of protein from tissue samples/ Western blotting
After terminal anaesthesia, the animals were killed by guillotine and brain samples immediately snap frozen in liquid nitrogen and stored at -70 ∞ C. For protein studies, we used duplicate 2 mm 3 samples comprising infarcted tissue, penumbra and corresponding areas in the contralateral hemisphere. After dissecting the infarcted area, the penumbra was defined as tissue adjacent to the infarcted core. Tissue samples (500 mg) were washed in ice-cold PBS and homogenized with a Teflon homogenizer at 4 ∞ C in 1.5 cm 3 of a buffer containing 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 0.5% sodium deoxycholate, 0.5% Nonidet P40, 0.1% SDS, 1 mM sodium vanadate and 5 m g/cm 3 aprotinin [52] . Extracts were sonicated, centrifuged (twice at 33 000 g , 15 min) and the supernatant containing solubilized enzymes was stored at -70 ∞ C. Protein concentrations were determined by the Bradford assay. Equal concentrations of protein (10 m g) from each lysate were mixed with 2 ¥ Laemmli buffer, vortex mixed and boiled for 15 min before application and separation along with prestained molecular weight markers by 12% SDS-PAGE. The proteins were electroblotted on to nitrocellulose filters (Hoefer, San Francisco, CA, USA) and the filters were blocked overnight with 1% BSA in TBS-Tween (50 mM Tris-HCl, pH 7.4; 200 mM NaCl and 1% Tween 20) . After blocking, filters were stained for 4 h at room temperature with primary antibody [phosphorylation specific and total protein specific or anti-a -actin polyclonal antibodies (Autogen Bioclear, CA, USA); 1 : 1000 in blocking buffer]. Filters were washed in TBS-Tween (5 ¥ ) for 3 min before staining with the appropriate peroxidase-conjugated secondary antibody (antirabbit, antimouse or antigoat 1 : 1000) for 1 h at room temperature. After washing in TBS-Tween (5 ¥ ) for 3 min, blots were developed using the ECL Western-blotting detection system (Amersham, Aylesbury, UK).
The amounts of phosphorylated protein and total protein expression recovered after Western blotting was measured on an LKB densitometer. Results are semiquantitative, and are given as a numerical increase or decrease (fold) compared with corresponding contralateral areas assigned an arbitrary value of one. ECL development times varied between experiments and therefore the intensity of staining between different blots is not directly comparable.
Results
Expression of phosphorylated protein
Cerebral grey and white matter homogenates derived from the infarcted and penumbra tissue of the ipsilateral and contralateral hemispheres demonstrated differential phosphorylation of signal transduction molecules.
Approximately 10 min after ischaemia (the time required to sacrifice the animal), there was a dramatic upregulation of p-ERK1/2 [17.0-and 20.0-fold increase, respectively, in grey matter stroke (GMs); Figure 1 a ], while an 8.0-and 9.5-fold increase, respectively, was seen in grey matter penumbra (GMp) (Figure 1 b ) . In GMs, p-TY staining increased notably and p-JNK1/2 expression increased by 12.6-and 3.0-fold, respectively (Figure 1 c ) .
Expression of p-p38, p-MEK3/6, p-Stat-1 and p-elk-1 did not change compared to the corresponding areas in the contralateral hemisphere. p-c-Jun was not detectable in these Western blots. There were no notable differences in the expression of any of the above proteins in the white matter of stroke and contralateral hemispheres.
At 1 h postischaemia , p-ERK1/2 expression was still elevated in the GMp (3.5-and 8.1-fold, respectively) and increased expression was observed in both white matter penumbra (WMp) and white matter stroke (WMs) (3.5-, 4.7-and 2.4-, 2.5-fold, respectively). An increase in p-TY was observed in the GMp (Figure 2 a ) . Expression of p-p38 increased by 14.0-fold in GMs and 4.0-fold in GMp, respectively (Figure 2 b , c ). p-JNK1/2 was increased only in the WMp (1.5-fold and 7.5-fold, respectively), while expression of p-elk-1 increased by 6.8-fold in the GMp (Figure 2 d ). There was no observable expression of p-Stat-1 or p-c-Jun.
At 4 h postischaemia , p-TY expression remained elevated in the GMp (Figure 3 a ) , while p-ERK1/2 was unchanged in both the stroke and penumbra tissue. Expression of p-p38 was unchanged in GMs, and slightly increased in GMp (1.5-fold). p-JNK expression remained unaltered in all areas, while p-Stat-1 was increased by 2.0-fold in GMp, compared to the contralateral hemisphere (Figure 3 b ) . There was no difference in expression of the above, phosphorylated proteins between stroke and contralateral hemispheres in the white matter.
At 12 h postischaemia , p-TY staining was not altered in either grey or white matter compared to the contralateral hemisphere. p-ERK1/2 (p44 kDa only) was increased in the GMs and GMp areas (3.0-and 5.0-fold, respectively), while in the WMp, it was increased by 1.5-and 3.8-fold, respectively. Expression of p-elk-1 was increased by 2.0-and 3.5-fold in GMs and GMp, respectively, while that of p-MEK3/6 was increased in GMs and GMp (4.0 and 6.0-fold, respectively; Figure 4 a , b ) . p-JNK-2 (p46) was increased in the WMs tissue (5.6-fold), p-Stat-1 was increased in WMs tissue by 6.5-fold and p-c-Jun was increased in the WMs, GMp and GMs tissue by 2.7-, 3.0-and 2.5-fold, respectively.
At 24 h postischaemia , there was increased expression of p-ERK1/2 (2.2-and 3.5-fold, respectively) in the GMp ( respectively). p-TY expression was also increased in the GMp. No differences in p-JNK, p-Stat-1 or p-c-Jun expression were seen. Expression of p-p38 increased by 3.2-fold in the GMp (Figure 5 b ), by 6.5-fold in the GMs and by 3.5-fold in the WMp, compared to the contralateral hemisphere. After 4 days , There was an increase in p-JNK-1 (p54 isoform) in the WMp (Figure 6 a) and GMp by 2.5-and 2.9-fold, respectively. Expression of p-p38 increased in both GMp by 16.5-fold (Figure 6 b ) and GMs tissue by 7.5-fold. p-Stat-1 expression increased by 2.5-fold in the GMs. There was no change in p-ERK1/2, p-TY or p-elk-1 expression and no observable expression of p-c-Jun. All results show blots stained in parallel with total protein specific antibodies as well as a -actin protein loading control.
Immunohistochemistry p-ERK1/2
In sham-operated rats there was basal expression of p-ERK1/2 in cortical layers II and III, ethorhinal cortex and ventro-medial thalamus. There was strong expression in the polymorphic neurones in the hilus of the hippocampus but not in the mossy fibres or pyramidal cells. There was some staining around the blood vessels but no staining in the corpus callosum. At 12 h postischaemia, there was a notable increase in staining in the ipsilateral hemisphere. Neurones and most of the glial cells in all the layers were strongly stained in the vicinity of the infarction. Staining was also seen in the ipsilateral corpus callosum, caudate and putamen. Staining in the contralateral hemisphere was similar to that in sham-operated rats. In the hippocampus, there was strong staining in neurones of the hilus. At 24 h, staining was strong but mainly in the glia and not in the neurones. Staining significantly increased throughout the corpus callosum. In the hippocampus, mossy fibres showed intense immunoreactivity. At longer time-points, that is, 4 days, 1 month and 2 months postischaemia, there was little staining in the infarcted and peri-infacted areas. However, many axons and dendrites still demonstrated immunoreactivity. Staining also disappeared from the hippocampus (Figure 7 ).
p-p38 MAP kinase
The staining pattern of this protein was almost identical to that of p-ERK1/2. However, staining of astroglial cells was prominent in both the infarcted and peri-infarcted regions even after 4 days. p-MEK3/6 At 30 min, only single neurones were stained in the infarcted area. At 12 h, staining was strictly confined to the peri-infarcted areas and mainly in single neurones. In deeper lesions, staining was present in the pericallosal neurones. At 24 h, there was staining in the neurones, often in all the layers in the infarcted and penumbra tissue and of a few astroglial cells. Staining was also seen in the corpus callosum and ethorhinal cortex. At 4 days, there was intensive staining in the infarcted areas mainly in the infiltrating cells, monocytes/microglia and some astroglial cells in all the layers. In the corpus callosum, there was intensive staining in the hippocampus (hilus, no staining at all in CA1 regions but more in the ipsilateral hemisphere) and in the basal regions in the Figure 7 . p-ERK1/2 immunohistochemistry. This figure demonstrates dramatic up-regulation of p-ERK1/2 family of molecules in the ipsilateral as compared to the contralateral hemisphere. This up-regulation was sustained for 12 h after ischaemia and was later decreased. Initially, p-ERK1/2 was expressed in both neurones ( a , arrow, 4 h) and astroglia, maintained for up to 24 h ( b ), but diminished rapidly by 4 days ( c ) with remaining positivity limited to the neuronal population. In the contralateral hemisphere expression was very weak ( ¥ 200, except top left ¥ 400).
ethorhinal cortex. In the extreme penumbra, there were positively stained small neurones in all the layers. At 1 month postischaemia, there was abundant staining in the infarcted and peri-infarcted areas and more neurones as well as axons were stained than at 2 months, and the pattern followed the gyries and showed basal staining in the ethorhinal cortex. There was staining of the neurones in the periventricular areas. At 2 months, there was strong staining in the infarcted area, mainly within glial cells and in the extracellular matrix. In the penumbra, pyramidal neurones were stained. At the vicinity of the infarction, large numbers of microglial cells were positively stained. There was basal staining in the ethorhinal cortex bilaterally (Figure 8 ).
p-Stat-1
There was strong staining of p-Stat-1 in the infarcted neurones and also in some glial cells at 12 h. Neurones around the infarct and in the corpus callosum stained more intensively than with anti-p-MEK3/6. After 24 h, there was more staining and some in the hilus of the hippocampus. At 4 days, more astroglia and monocytes/ macrophages and some neurones in the extreme penumbra were stained. There was abundant staining in the corpus callosum and also in the basal ganglia and some in the hilus of the hippocampus. At 1 month, staining was limited to the neurones in the old peri-infarcted area. At 2 months, there was no cellular staining ( Figure 9 ). p-elk-1 At 12 h after experimental ischaemia, there was a significant increase in staining in the ipsilateral hemisphere. Neurones and most of the glial cells in all the layers were strongly stained in the vicinity of the infarction. There was no staining in the contralateral hemisphere. At 24 h, staining was strong but confined mainly to the glia and not in the neurones. Staining significantly increased throughout the corpus callosum. In the hippocampus, mossy fibres showed intense immunoreactivity. At 1 month postischaemia, staining largely disappeared from the infarcted and peri-infacted areas. However, many axons and dendrites still demonstrated immunoreactivity, while staining disappeared from the hippocampus (Figure 10 ).
p-JNK p-JNK was transiently increased following focal ischaemia. Its expression was mainly limited to the infarcted core tissue at earlier time-points. At 12 and 24 h, there was also some expression in neurones within the penumbra. At later time-points, that is, 4 days, 7 days and 1 month, there was almost no expression of p-JNK either in the stroke or in the contralateral hemisphere (Figure 11 ). p-TY There was a very strong and homogenous expression of p-TY throughout the cortex and white matter in both infarcted and contralateral hemispheres. This expression slightly increased as the ischeamia progressed up to 4 days. At 1 month, there was only weak expression that was similar in both hemispheres.
p-c-Jun
This molecule was very selectively expressed in the infarcted but not in the contralateral hemisphere. Expression was induced within 4 h of ischaemia and was sustained up to 4 days. p-c-Jun was almost exclusively expressed in neurones and some microvascular endothelial cells.
Discussion
Here, we have demonstrated that shortly after ischaemia there was notable phosphorylation of signal transduction intermediates associated with angiogenic and neuronal protective/apoptotic mechanisms. The most obvious changes occurred in the grey matter. There was a notable increase in expression of tyrosine phosphorylated proteins (p-TY) at the earliest time-points (0-1 h), while later on, a redistribution rather than change in concentration of these proteins occurred. An increase in p-ERK1/2, p-JNK1/2 and p-p38 (together with its activator p-MEK3/6) occurred soon after ischaemia. IHC showed these changes appeared in the infarcted tissue, and spread with time towards the penumbra. p-Stat-1 and p-c-Jun were expressed in a delayed fashion, only at the later timepoints. Differential phosphorylation of the above molecules occurred but to a lesser extent in the white matter.
These results support our earlier findings in humans, that activation of the MAP kinase family is important during early evolution of the infarction [15, 47] . Results from immunohistochemical studies confirm the results of Western blotting and show that cell expression of p-ERK1/2 at the early time-points occurred mainly in the neuronal population, with some expression around Figure 10 . p-elk-1 immunohistochemistry. (a) At 12 h after experimental ischaemia, there was significant increase in expression of p-elk-1 in the ipsilateral hemisphere. Neurones and most of the glial cells in all the layers were strongly stained at the vicinity of the infarction (arrows, ¥ 100). There was no staining in the contralateral hemisphere. At 24 h, staining was strong but mainly in the glia and not in the neurones. Staining significantly increased throughout the corpus callosum. In the hippocampus, mossy fibres showed intense immunoreactivity. At 1 month postischaemia, immunoreactivity mostly disappeared from the infarcted and peri-infacted areas. However, many axons and dendrites still demonstrated immunoreactivity. Staining disappeared from the hippocampus. the blood vessels. This pattern of expression persisted for 12 and 24 h postischaemia. The existence of selective regional vulnerability to sustained activation of the MAP kinase pathway has previously been demonstrated [37] , while rapid phosphorylation of ERK1/2 in rat cerebellar granule neurones by BDNF protected against caspase-3 activation and tissue loss [11] . Activation of the Ras-MAP kinase pathway by nitric oxide in gerbil hippocampal neurones was critical for the development of tolerance to oxygen-glucose deprivation [10] . However, it was also reported that hypoxia-ischaemia-induced activation of the ERK pathway might contribute to damage resulting from focal cerebral ischaemia [1] . Inhibitors of MEK phosphorylation were associated with protection against synaptic excitotoxicity in association with MAP kinase activation in rat hippocampal neurones [44] . Similarly, reperfusion injury in mice with focal cerebral ischaemia was significantly reduced following administration of UO126, a specific MEK inhibitor [29] . ERK activation might have both beneficial and detrimental effects leading to prolonged survival or apoptosis. In this study, p-ERK1/2 had two peaks of expression: the most notable occurring within 1 h of induction of the infarct. This could result from release of growth factors by infiltrating macrophages, damaged cells and tissue as seen during the wound healing response [25] . Stimulation of neurotransmitter receptors, such as muscarinic acetylcholine receptors, also results in prolonged activation of ERK1/2 [35] . A variety of agents such as ligands for specific neurotransmitter receptors [8] , nitric oxide [59] and oestrogen [43] can activate the neuronal ERK pathway in vitro.
A constituitively activated MAP kinase pathway may initiate and promote angiogenesis, leading to tissue reperfusion, which is important for neuronal survival in the penumbra region [47, 50] . The MEK inhibitor PD98059 inhibited mitogenesis of human umbilical vein endothelial cells (ECs) [55] and also following stimulation with VEGF [58] . Our results show an initial transient association of p-ERK1/2 with neighbouring blood vessels and a short lasting activation of p-ERK1/2 in the penumbra region. This could be a limiting factor in determining the rate of capillary regrowth. Our unpublished data showed a time lag of 7 days in notable revascularization in the ischaemic penumbra of rats following MCAO, suggesting the initial surge in expression of these molecules is not sufficient to stimulate angiogenesis. Improved tissue and neuronal survival could be obtained by manipulation of both the time-course and localization of p-ERK1/2 after stroke.
Irving et al. [15] reported differential expression of phosphorylated MAP kinase/ERK and p38/SAPK pathways after focal cerebral ischaemia. p-ERKs were expressed mainly in the neuronal population and p-p38 in astroglial cells. p-p38 MAP kinase but not p-p42 or p-p44 was detected in rats after global forebrain ischaemia in microglia near dying CA1 neurones [54] . We showed an increase in expression of p-p38 immediately (within 30 min) after infarction mainly associated with neurones. However, p-p38 became more abundantly associated with astroglial cells after 12-24 h, remaining after 4 days. Other studies have shown localization of p-p38 in astrocyte like cells following MCAO in the rat, rather than in dying neurones [15] . Upon phosphorylation of Thr and Tyr residues, p38 MAP kinase transduces stress-related signals in eukaryotic cells, resulting in activation of downstream transcription factors ATF-2 and CHOP-1 [12] . Also, p-p38 can phosphorylate MAP kinase AP-2 and MAP kinase AP-3 which regulate Hsp-27, increase expression of pro-inflammatory cytokines such as IL-6 and TNF-a, and induce an inflammatory cascade, increasing infarction volume, cellular damage and stimulating apotosis [27, 28] . It was suggested that after cerebral ischaemia, p38 MAP kinase participates in the inflammatory microglia/macrophage response [54] . Administration of the p38 MAP kinase inhibitor SE 239063 reduced infarct size in a rat focal ischaemic stroke model by 28-41% [20] . Similarly, neurological deficits were reduced by 25-35%. Other studies have shown a significant reduction in infarct size in a pig model of cardiac ischaemia after local infusion of the p38 inhibitor SB 203580 [28] . Inhibition of p38 phosphorylation probably reduces infarct size and neuronal cell death by inhibition of inflammatory cytokine production [4, 5] . We observed an increase in p-p38 expression even after 4 days, suggesting chronic activation could be partly responsible for poor recovery. Similarly, p-MEK3/6 was increased in both the infarcted and penumbral regions soon after stroke. Like p-p38, it was initially associated with the neuronal population but extended to include microglia and astroglia positive cells from 24 h onwards, remaining even after 1-2 months.
In relation to angiogenesis, we demonstrated only a transient (< 12 h) association of p-p38 with penumbral blood vessels. Other work showed that the specific p38 inhibitor SB 203580 reduced FGF-2-mediated tube formation in MSS31 ECs in type I collagen gel [50] , and VEGFinduced cell migration [41] . Similarly, treatment of bovine capillary ECs with SB 202190 resulted in increased FGF-2-induced tubular morphogenesis by decreasing apoptosis and increasing DNA synthesis and cell proliferation [36] . These in vitro studies suggest that phosphorylation of p38 in ECs in vivo might be one mechanism that inhibits revascularization after stroke.
JNK phosphorylation can occur in response to cytokines such as TNF-a and IL-1, and also through cellular stress stimuli such as UV light and heat shock [26] , and result in c-Jun and ATF-2 activation [12, 20] . These transcription factors, along with others, comprise the AP-1 complex, which can initiate neuronal apoptosis [34] . NGF deprivation caused an increase in JNK activity in sympathetic neurones resulting in apoptosis, while suppression of this activity rescued the neurones [57] . Similarly, in cerebellar granule neurones deprived of survival factors, the JNK substrate p-c-Jun was increased and the neurones died from apoptosis [53] . However, expression of a dominant negative form of c-Jun protected the neurones. The neurones expressed high basal levels of p-JNK, suggesting there was an alternative pathway responsible for activating c-Jun. In our study, we also showed high initial expression of p-JNK1/2 in the infarcted core tissue, while p-c-Jun increased only after 4 h. Both p-JNK and p-c-Jun were localized primarily in the infarcted region and associated with dead or dying neurones. Activation of JNK in neuronal cells in this region, could be a predeterminant of apoptotic cell death. Similarly, prolonged c-Jun phosphorylation after MCAO in the rat was present in neurones in the necrotic infarct areas up to 72 h after ischaemia [56] . Although phosphorylation of JNK1/2 can stabilize and induce VEGF mRNA expression [31] and also induce ECV304 EC motility [40] , we could not detect its association with affected EC in the penumbra region. Therefore, p-JNK1/2 was most probably primarily associated with activation of the apoptotic pathway in dead or dying neurones.
Phosphorylation of both JNK and ERK is associated with induction of early response genes and hyperphosphorylation of elk-1 and c-AMP/calcium-responsive elementbinding protein [38] . Stat-1, a signal transducer and transcriptional activator, was chronically phosphorylated from 4 days onwards, after transient focal ischaemia [22] . Activation of Stat-1 in cos-7 cells after hyperosmotic shock occurred via p-p38 [6] , while Stat-1 and Stat-3 were phosphorylated in astrocytes and neurones after transient focal cerebral ischaemia in the rat [17] . p-elk-1 and p-Stat-1 were expressed within 12 h of MCAO, mainly restricted to the neuronal population. Their association with dead or dying neurones also suggests a role in apotosis.
It seems that differences in peak expression between ERKs and molecules related to the induction of apoptosis may be different. Proteins which can protect against neuronal damage or stimulate angiogenesis may not become activated, or remain activated to the maximum degree, at the most important time-points to improve recovery. Therefore, potential treatments could be considered which maximize pro-angiogenic activity and inhibit components that promote apoptosis and neuronal cell death.
Biochemical cascades occurring after brain ischaemia involve many cytokines, growth factors, oxidative stress molecules and neurocytotoxic substances that are activated and released very often simultaneously. This complexity of signalling interactions explains why efforts to identify a single marker of brain ischaemia have failed so far. A novel approach may be to characterize the family of intracellular proteins activated in response to toxicischaemic insult. These molecules will directly modulate the subsequent transcriptional response. In conclusion, it seems that the tyrosine kinase pathway becomes upregulated early after induction of stroke, and leads to subsequent activation of the MAP kinase family of molecules at early time-points and also the JAK/Stat-1 family at later time-points. Identification of molecular communication between different signal transduction pathways may have a crucial significance in understanding the dynamics of ischaemic penumbra.
